Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Kamimoto

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|December 9, 2010
Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic ratsYasushi Kirino, Youichi Sato, Takayuki Kamimoto, et al.
Frontiers in Neurology|August 4, 2023
Estimation of minimal detectable change in the 10-meter walking test for patients with stroke: a study stratified by gait speedYuichiro Hosoi, Takayuki Kamimoto, Katsuya Sakai, et al.
Asia-Pacific Journal of Public Health|March 12, 2025
Impact of the COVID-19 Pandemic on Physical Function Among Community-Dwelling People With Disabilities in Japan: A Follow-Up StudyTakayuki Kamimoto, Michiyuki Kawakami, Hikaru Matsunaga, et al.
The Journal of Endocrinology|October 22, 2008
Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient ratsYasushi Kirino, Youichi Sato, Takayuki Kamimoto, et al.
Journal of Rehabilitation Medicine|November 11, 2025
Clinical assessments and gait characteristics by subtype classification using temporal and kinematic symmetry indices during gait in patients with chronic strokeYuichiro Hosoi, Takayuki Kamimoto, Kohsuke Okada, et al.
Journal of Rehabilitation Medicine|April 21, 2026
Beyond spasticity reduction: botulinum toxin-a injection is associated with changes in abnormal flexor synergies of the upper limb in chronic strokeMichiyuki Kawakami, Daisuke Ito, Ken Azuma, et al.
Biological & Pharmaceutical Bulletin|March 3, 2009
Increased plasma dipeptidyl peptidase IV (DPP IV) activity and decreased DPP IV activity of visceral but not subcutaneous adipose tissue in impaired glucose tolerance rats induced by high-fat or high-sucrose dietYasushi Kirino, Takayuki Kamimoto, Youichi Sato, et al.
Journal of Neuroengineering and Rehabilitation|December 26, 2024
Development of a quantitative assessment for abnormal flexor synergy index in patients with stroke: a validity and responsiveness studyDaisuke Ito, Michiyuki Kawakami, Yuichiro Hosoi, et al.
Life Sciences|November 5, 2010
Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathwayYouichi Sato, Sakura Koshioka, Yasushi Kirino, et al.
BMC Gastroenterology|April 24, 2025
Mapping of rehabilitation interventions and assessment methods for patients with liver cirrhosis: a scoping reviewYuichiro Hosoi, Michiyuki Kawakami, Daisuke Ito, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Endocrinology and Metabolism|December 9, 2010
Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic ratsYasushi Kirino, Youichi Sato, Takayuki Kamimoto, et al.
Frontiers in Neurology|August 4, 2023
Estimation of minimal detectable change in the 10-meter walking test for patients with stroke: a study stratified by gait speedYuichiro Hosoi, Takayuki Kamimoto, Katsuya Sakai, et al.
Asia-Pacific Journal of Public Health|March 12, 2025
Impact of the COVID-19 Pandemic on Physical Function Among Community-Dwelling People With Disabilities in Japan: A Follow-Up StudyTakayuki Kamimoto, Michiyuki Kawakami, Hikaru Matsunaga, et al.
The Journal of Endocrinology|October 22, 2008
Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient ratsYasushi Kirino, Youichi Sato, Takayuki Kamimoto, et al.
Journal of Rehabilitation Medicine|November 11, 2025
Clinical assessments and gait characteristics by subtype classification using temporal and kinematic symmetry indices during gait in patients with chronic strokeYuichiro Hosoi, Takayuki Kamimoto, Kohsuke Okada, et al.
Journal of Rehabilitation Medicine|April 21, 2026
Beyond spasticity reduction: botulinum toxin-a injection is associated with changes in abnormal flexor synergies of the upper limb in chronic strokeMichiyuki Kawakami, Daisuke Ito, Ken Azuma, et al.
Biological & Pharmaceutical Bulletin|March 3, 2009
Increased plasma dipeptidyl peptidase IV (DPP IV) activity and decreased DPP IV activity of visceral but not subcutaneous adipose tissue in impaired glucose tolerance rats induced by high-fat or high-sucrose dietYasushi Kirino, Takayuki Kamimoto, Youichi Sato, et al.
Journal of Neuroengineering and Rehabilitation|December 26, 2024
Development of a quantitative assessment for abnormal flexor synergy index in patients with stroke: a validity and responsiveness studyDaisuke Ito, Michiyuki Kawakami, Yuichiro Hosoi, et al.
Life Sciences|November 5, 2010
Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathwayYouichi Sato, Sakura Koshioka, Yasushi Kirino, et al.
BMC Gastroenterology|April 24, 2025
Mapping of rehabilitation interventions and assessment methods for patients with liver cirrhosis: a scoping reviewYuichiro Hosoi, Michiyuki Kawakami, Daisuke Ito, et al.
Pageof 2